Computational Biologist Eleanor Howe Delivers Candid Assessment of Drug Discovery's Digital Transformation at Bio-IT World 2026
Summary
Eleanor Howe delivered the annual "Trends from the Trenches" address at Bio-IT World Conference & Expo 2026, offering a candid, buzzword-free perspective on the digital transformation of drug discovery. The session, founded by Chris Dagdigian over two decades ago as an antidote to corporate sales pitches, maintained its tradition of honest, independent analysis. Howe discussed the real-world impact of AI, computational biology, and data-driven approaches on pharmaceutical R&D, drawing from frontline experience rather than vendor narratives.
Source
bskyComputational Biologist Eleanor Howe Delivers Candid Assessment of Drug Discovery's Digital Transformation at Bio-IT World 2026bio-itworld.comKey quotes
· 3 pulledNo buzzwords, no vendor spin, and no marketing varnish.
The session was created as a deliberate corrective to what Dagdigian called 'thinly disguised sales pitches delivered by a C-suite suit.'
Since then, Dagdigian and others through the years have held firm to the candid and independent spirit of the talk.
You might also wanna read
AI Advances in Drug Discovery: From Data Integration to Dual-Action Cancer Drug Design
The article discusses recent advancements in AI-driven drug discovery, highlighting two key developments: 1) Analytica 2026, an event focuse
drugtargetreview.com·5mo ago
Exploring Biological Data Representation: A Conversation with Sterling Hooten
This article appears to be a transcript or summary of a conversation with Sterling Hooten about a novel concept described as "the printing p
owlposting.com·2mo ago
Verge Genomics Hiring for Engineering and Product Roles to Advance AI Drug Discovery
Verge Genomics, an AI drug discovery company, is hiring for multiple engineering and product roles including Head of Product & Engineering,
news.ycombinator.com·8mo ago
Reflections on 2024 Bio-ML Predictions: Generative Chemistry and Molecular Dynamics Challenges
The article reflects on the author's 2024 predictions about bio-ML (biological machine learning) from a 2026 perspective, focusing on genera
owlposting.com·5mo ago
How LLMs Are Transforming Preclinical Drug Discovery Data Access
The article discusses how Large Language Models (LLMs) are being applied to preclinical drug discovery to help researchers efficiently acces
Google DeepMind CEO claims goal of "solving all disease" through AI drug discovery
This special early edition of The Verge's Optimizer newsletter, tied to Google I/O coverage, contextualizes a bold claim made by Google Deep
The Verge·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.